Imatinib therapy for chronic myeloid leukemia: Where do we go now?

Jorge E. Cortes

doi:10.1200/JCO.2008.16.9870

Imatinib therapy for chronic myeloid leukemia: Where do we go now?

Jorge E. Cortes

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	3308-3309
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	26
Issue number	20
DOIs	https://doi.org/10.1200/JCO.2008.16.9870
State	Published - 2008
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2008.16.9870

Cite this

@article{a05cf6123da743f084bd0c274143bc96,

title = "Imatinib therapy for chronic myeloid leukemia: Where do we go now?",

author = "Cortes, \{Jorge E.\}",

year = "2008",

doi = "10.1200/JCO.2008.16.9870",

language = "English (US)",

volume = "26",

pages = "3308--3309",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "20",

}

TY - JOUR

T1 - Imatinib therapy for chronic myeloid leukemia

T2 - Where do we go now?

AU - Cortes, Jorge E.

PY - 2008

Y1 - 2008

UR - https://www.scopus.com/pages/publications/49149121616

UR - https://www.scopus.com/pages/publications/49149121616#tab=citedBy

U2 - 10.1200/JCO.2008.16.9870

DO - 10.1200/JCO.2008.16.9870

M3 - Editorial

C2 - 18519950

AN - SCOPUS:49149121616

SN - 0732-183X

VL - 26

SP - 3308

EP - 3309

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 20

ER -

Imatinib therapy for chronic myeloid leukemia: Where do we go now?

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this